Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs)

Oligonucleotides

Volumn 18, Issue 3, 2008, Pages 201-212

  Viel, Thomas ^a   Boisgard, Raphael ^a   Kuhnast, Bertrand ^a   Jego, Benoit ^a   Siquier Pernet, Karine ^a   Hinnen, Francoise ^a   Dolle, Frederic ^a   Tavitian, Bertrand ^a  

^a DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; RIBOSE; SMALL INTERFERING RNA;

ARTICLE; BIOAVAILABILITY; CHEMICAL MODIFICATION; CONJUGATION; GENE FUNCTION; HUMAN; HUMAN CELL; KIDNEY; LIVER; MACROMOLECULE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RNA INTERFERENCE; RNA SEQUENCE; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE, TUMOR; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; WHOLE BODY IMAGING;

RODENTIA;

EID: 51849089779     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0133     Document Type: Article

References (53)

1. AGRAWAL, S., TEMSAMANI, J., GALBRAITH, W., and TANG, J. (1995). Pharmacokinetics of antisense oligonucleotides. Clin. Pharmacokinet. 28, 7-16.
2. AIGNER, A. (2006). Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J. Biotechnol. 124, 12-25.
3. AMARZGUIOUI, M., HOLEN, T., BABAIE, E., and PRYDZ, H. (2003). Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31, 589-595.
4. BARTLETT, D.W., SU, H., HILDEBRANDT, I.J., WEBER, W.A., and DAVIS, M.E. (2007). Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. USA 104, 15549-15554.
5. BEHLKE, M.A. (2006). Progress towards in vivo use of siRNAs. Mol. Ther. 13, 644-670.
6. BRAASCH, D.A., PAROO, Z., CONSTANTINESCU, A., REN, G., OZ, O.K., MASON, R.P., and COREY, D.R. (2004). Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg. Med. Chem. Lett. 14, 1139-1143.
7. CEJKA, D., LOSERT, D., and WACHECK, V. (2006). Short interfering RNA (siRNA): tool or therapeutic? Clin. Sci. (Lond.) 110, 47-58.
8. CHIU, Y.L., and RANA, T.M. (2003). siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048.
9. CZAUDERNA, F., FECHTNER, M., DAMES, S., AYGUN, H., KLIPPEL, A., PRONK, G.J., GIESE, K., and KAUFMANN, J. (2003). Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705-2716.
10. DOENCH, J.G., PETERSEN, C.P., and SHARP, P.A. (2003). siRNAs can function as miRNAs. Genes Dev. 17, 438-442.
11. DUATTI, A. (2004). In vivo imaging of oligonucleotides with nuclear tomography. Curr. Drug Targets 5, 753-760.
12. DUXBURY, M.S., ITO, H., ZINNER, M.J., ASHLEY, S.W., and WHANG, E.E. (2004a). RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene 23, 1539-1548.
13. DUXBURY, M.S., MATROS, E., ITO, H., ZINNER, M.J., ASHLEY, S.W., and WHANG, E.E. (2004b). Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg 240, 667-674; discussion 675-676.
14. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K ., and TUSCHL, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
15. FILLEUR, S., COURTIN, A., AIT-SI-ALI, S., GUGLIELMI, J., MERLE, C., HAREL-BELLAN, A., CLEZARDIN, P., and CABON, F. (2003). siRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 63, 3919-3922.
16. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
17. FLYNN, M.A., CASEY, D.G., TODRYK, S.M., and MAHON, B.P. (2004). Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo. J. Inflamm. (Lond) 1, 4.
18. GARTEL, A.L., and KANDEL, E.S. (2006). RNA interference in cancer. Biomol Eng 23, 17-34.
19. GRINDEL, J.M., MUSICK, T.J., JIANG, Z., ROSKEY, A., and AGRAWAL, S. (1998). Pharmacokinetics and metabolism of an oligodeoxynucleotide phosphorothioate (GEM91) in cynomolgus monkeys following intravenous infusion. Antisense Nucleic Acid Drug. Dev. 8, 43-52.
20. HNATOWICH, D.J., MARDIROSSIAN, G., FOGARASI, M., SANO, T., SMITH, C.L., CANTOR, C.R., RUSCKOWSKI, M., and WINNARD, P., JR. (1996). Comparative properties o f a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice. J. Pharmacol. Exp. Ther. 276, 326-334.
21. HORNUNG, V., GUENTHNER-BILLER, M., BOURQUIN, C., ABLASSER, A., SCHLEE, M., UEMATSU, S., NORONHA, A., MANOHARAN, M., AKIRA, S., DE FOUGEROLLES, A., ENDRES, S., and HARTMANN, G. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270.
22. JACKSON, A.L., BARTZ, S.R., SCHELTER, J., KOBAYASHI, S.V., BURCHARD, J., MAO, M., LI, B., CAVET, G., and LINSLEY, P.S. (2003). Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21, 635-637.
23. JACKSON, A.L., BURCHARD, J., LEAKE, D., REYNOLDS, A., SCHELTER, J., GUO, J., JOHNSON, J.M., LIM, L., KARPILOW, J., NICHOLS, K., MARSHALL, W., KHVOROVA, A., and LINSLEY, P.S. (2006). Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12, 1197-1205.
24. JORGENSEN, R.A., CLUSTER, P.D., ENGLISH, J., QUE, Q., and NAPOLI, C.A. (1996). Chalcone synthase cosuppression phenotypes in petunia flowers: comparison of sense vs. antisense constructs and single-copy vs. complex T-DNA sequences. Plant. Mol. Biol. 31, 957-973.
25. JUDGE, A.D., BOLA, G., LEE, A.C., and MACLACHLAN, I. (2006). Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13, 494-505.
26. KUHNAST, B., DE BRUIN, B., HINNEN, F., TAVITIAN, B., and DOLLE, F. (2004). Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F] fluoropyridin-3-yloxy)propyl] acetamide. Bioconjug. Chem. 15, 617-627.
27. KUHNAST, B., DOLLE, F., TERRAZZINO, S., ROUSSEAU, B., LOC'H, C., VAUFREY, F., HINNEN, F., DOIGNON, I., PILLON, F., DAVID, C., CROUZEL, C., and TAVITIAN, B. (2000). General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug. Chem. 11, 627-636.
28. KUHNAST, B., KLUSSMANN, S., HINNEN, F., BOISGARD, R., ROUSSEAU, B., FÜRSTE, J.P., TAVITIAN, B., and DOLLÉ, F. (2003). Fluorine-18- and Iodine-125 labelling of spiegelmers. J . Label. Compd. Radiopharm. 46, 1205-1219.
29. LAYZER, J.M., MCCAFFREY, A.P., TANNER, A.K., HUANG, Z., KAY, M.A., and SULLENGER, B.A. (2004). In vivo activity of nuclease-resistant siRNAs. RNA 10, 766-771.
30. LIANG, Z., YOON, Y., VOTAW, J., GOODMAN, M.M., WILLIAMS, L., and SHIM, H. (2005). Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65, 967-971.
31. LIU, N., DING, H., VANDERHEYDEN, J.L., ZHU, Z., and ZHANG, Y. (2007). Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution. Nucl. Med. Biol. 340, 399-404.
32. MAGGI, A., OTTOBRINI, L., BISERNI, A., LUCIGNANI, G., and CIANA, P. (2004). Techniques: reporter mice - a new way to look at drug action. Trends Pharmacol. Sci. 25, 337-342.
33. MANOHARAN, M. (2004). RNA interference and chemically modified small interfering RNAs. Curr. Opin. Chem. Biol. 8, 570-579.
34. MEDAROVA, Z., PHAM, W., FARRAR, C., PETKOVA, V., and MOORE, A. (2007). In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13, 372-377.
35. NAPOLI, C., LEMIEUX, C., and JORGENSEN, R. (1990). Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2, 279-289.
36. PAN, D., GAMBHIR, S.S., TOYOKUNI, T., IYER, M.R., ACHARYA, N., PHELPS, M.E., and BARRIO, J.R. (1998). Rapid synthesis of a 5′-fluorinated oligodeoxy-nucleotide: a model antisense probe for use in imaging with positron emission tomography (PET). Bioorg. Med. Chem. Lett. 8, 1317-1320.
37. PERSENGIEV, S.P., ZHU, X., and GREEN, M.R. (2004). Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12-18.
38. PRAKASH, T.P., ALLERSON, C.R., DANDE, P., VICKERS, T.A., SIOUFI, N., JARRES, R., BAKER, B.F., SWAYZE, E.E., GRIFFEY, R.H., and BHAT, B. (2005). Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 48, 4247-4253.
39. ROBBINS, M.A., and ROSSI, J.J. (2005). Sensing the danger in RNA. Nat. Med. 11, 250-251.
40. SCHMIDT, K.S., BORKOWSKI, S., KURRECK, J., STEPHENS, A.W., BALD, R., HECHT, M., FRIEBE, M., DINKELBORG, L., and ERDMANN, V.A. (2004). Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res. 32, 5757-5765.
41. SEMIZAROV, D., KROEGER, P., and FESIK, S. (2004). siRNA-mediated gene silencing: a global genome view. Nucleic Acids Res. 32, 3836-3845.
42. SLEDZ, C.A., HOLKO, M., DE VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839.
43. SORENSEN, D.R., LEIRDAL, M., and SIOUD, M. (2003). Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol., 327, 761-766.
44. SOUTSCHEK, J., AKINC, A., BRAMLAGE, B., CHARISSE, K., CONSTIEN, R., DONOGHUE, M., ELBASHIR, S., GEICK, A., HADWIGER, P., HARBORTH, J., JOHN, M., KESAVAN, V., LAVINE, G., PANDEY, R.K., RACIE, T., RAJEEV, K.G., ROHL, I., TOUDJARSKA, I., WANG, G., WUSCHKO, S., BUMCROT, D., KOTELIANSKY, V., LIMMER, S., MANOHARAN, M., and VORNLOCHER, H.P. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173-178.
45. TAVITIAN, B. (2003). In vivo imaging with oligonucleotides for diagnosis and drug development. Gut 52(Suppl 4), iv, 40-47.
46. TAVITIAN, B., TERRAZZINO, S., KUHNAST, B., MARZABAL, S., STETTLER, O., DOLLE, F., DEVERRE, J.R., JOBERT, A., HINNEN, F., BENDRIEM, B., CROUZEL, C., and DI GIAMBERARDINO, L. (1998). In vivo imaging of oligonucleotides with positron emission tomography. Nat. Med. 4, 467-471.
47. TOUB, N., MALVY, C., FATTAL, E., and COUVREUR, P. (2006). Innovative nanotechnologies for the delivery of oligonucleotides and siRNA. Biomed. Pharmacother. 60, 607-620.
48. UPRICHARD, S.L. (2005). The therapeutic potential of RNA interference. FEBS Lett. 579, 5996-6007.
49. VAN DE WATER, F.M., BOERMAN, O.C., WOUTERSE, A.C., PETERS, J.G., RUSSEL, F.G., and MASEREEUW, R. (2006). Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab. Dispos. 34, 1393-1397.
50. VIEL, T., KUHNAST, B., HINNEN, F., BOISGARD, R., TAVITIAN, B., and DOLLÉ, F. (2007). Fluorine-18 labelling of small interfering RNAs (siRNAs) for PET imaging. J. Label. Compounds Radiopharm. 50, 1159-1168.
51. WOLFRUM, C., SHI, S., JAYAPRAKASH, K.N., JAYARAMAN, M., WANG, G., PANDEY, R.K., RAJEEV, K.G., NAKAYAMA, T., CHARRISE, K., NDUNGO, E.M., ZIMMERMANN, T., KOTELIANSKY, V., MANOHARAN, M., and STOFFEL, M. (2007). Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149-1157.
52. XIE, F.Y, WOODLE, M.C., and LU, P.Y. (2006). Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov. Today 11, 67-73.
53. ZIMMERMANN, T.S., LEE, A.C., AKINC, A., BRAMLAGE, B., BUMCROT, D., FEDORUK, M.N., HARBORTH, J., HEYES, J.A., JEFFS, L.B., JOHN, M., JUDGE, A.D., LAM, K., MCCLINTOCK, K., NECHEV, L.V., PALMER, L.R., RACIE, T., ROHL, I., SEIFFERT, S., SHANMUGAM, S., SOOD, V., SOUTSCHEK, J., TOUDJARSKA, I., WHEAT, A.J., YAWORSKI, E., ZEDALIS, W., KOTELIANSKY, V., MANOHARAN, M., VORNLOCHER, H.P., and MACLACHLAN, I. (2006). RNAi-mediated gene silencing in non-human primates. Nature 441, 111-114.